In vivo up‐regulation of brain‐derived neurotrophic factor in specific brain areas by chronic exposure to Δ9‐tetrahydrocannabinol
Authors:
- 22 April 2005
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 93 (4) , 802-811
Abstract
Cannabinoids are widely abused drugs. Here we show that chronic administration of Δ9‐tetrahydrocannabinol (Δ9‐THC), the active psychotropic agent in marijuana and hashish, at 1.5 mg per kg per day intraperitoneally for 7 days, increases the expression, at both mRNA and protein levels, of brain‐derived neurotrophic factor (BDNF), in specific rat brain areas, notably in those involved in reward and addiction. Real‐time PCR revealed a 10‐fold up‐regulation of BDNF mRNA in the nucleus accumbens (NAc) upon chronic Δ9‐THC treatment, but there was no change at 3 or 24 h after a single injection. Smaller increases in mRNA levels were found in the ventral tegmental area (VTA), medial prefrontal cortex and paraventricular nucleus (PVN). Immunohistochemistry showed large increases in BDNF‐stained cells in the NAc (5.5‐fold), posterior VTA (4‐fold) and PVN (1.7‐fold), but no change was observed in the anterior VTA, hippocampus or dorsal striatum. Altogether, our study indicates that chronic exposure to Δ9‐THC up‐regulates BDNF in specific brain areas involved with reward, and provides evidence for different BDNF expression in the anterior and posterior VTA. Moreover, BDNF is known to modulate synaptic plasticity and adaptive processes underlying learning and memory, leading to long‐term functional and structural modification of synaptic connections. We suggest that Δ9‐THC up‐regulation of BDNF expression has an important role in inducing the neuroadaptive processes taking place upon exposure to cannabinoids.Keywords
This publication has 77 references indexed in Scilit:
- A SingleIn VivoExposure to Cocaine Abolishes Endocannabinoid-Mediated Long-Term Depression in the Nucleus AccumbensJournal of Neuroscience, 2004
- Involvement of brain‐derived neurotrophic factor in cannabinoid receptor‐dependent protection against excitotoxicityEuropean Journal of Neuroscience, 2004
- Exogenous and Endogenous Cannabinoids Control Synaptic Transmission in Mice Nucleus AccumbensAnnals of the New York Academy of Sciences, 2003
- SHORT COMMUNICATION Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoidsEuropean Journal of Neuroscience, 2002
- Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s diseaseProgress in Neurobiology, 2001
- Hydroxypropyl-β-cyclodextrin and its combination with hydroxypropyl-methylcellulose increases aqueous solubility of Δ9-tetrahydrocannabinolLife Sciences, 1998
- Endogenous cannabinoids as an aversive or counter-rewarding system in the ratNeuroscience Letters, 1997
- Conditioned place preference induced by Δ9-tetrahydrocannabinol: comparison with cocaine, morphine, and food rewardLife Sciences, 1995
- Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNAEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- The Metabolism of Δ9‐Tetrahydrocannabinol and Related Cannabinoids in ManThe Journal of Clinical Pharmacology, 1981